VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNISATION AGAINST HIV

Details for Australian Patent Application No. 2002355653 (hide)

Owner GLAXOSMITHKLINE BIOLOGICALS S.A. GLAXO GROUP LIMITED

Inventors ERTL, Peter, Franz; VOSS, Gerald; VAN WELY, Catherine, Ann; TITE, John, Philip

Pub. Number AU-A-2002355653

PCT Number PCT/EP02/08343

PCT Pub. Number WO2003/011334

Priority 0118367.2 27.07.01 GB

Filing date 26 July 2002

Wipo publication date 17 February 2003

International Classifications

A61K 031/713 - Double-stranded nucleic acids or oligonucleotides

C12N 015/89 Mutation or genetic engineering

C07K 019/00 Hybrid peptides

C07K 014/16 Peptides having more than 20 amino acids

C12N 015/49 Mutation or genetic engineering

A61K 039/21 Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0118367.2 27.07.01 GB

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002355653

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002355654-POLYVALENT VACCINE AGAINST DISEASES CAUSED BY PAPILLOMA VIRUSES, METHOD FOR THE PRODUCTION AND THE USE THEREOF

2002355652-2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-( 1,1-dioxo-1lambda6-thiomorpholin-4-yl) -4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobut yramide